» Authors » Maureen Chase

Maureen Chase

Explore the profile of Maureen Chase including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 800
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Donnino M, Berg K, Vine J, Balaji L, Berlin N, Cocchi M, et al.
Resuscitation . 2024 Mar; 198:110158. PMID: 38428720
Introduction: Thiamine is a key cofactor for aerobic metabolism, previously shown to improve mortality and neurological outcomes in a mouse model of cardiac arrest. We hypothesized that thiamine would decrease...
2.
Moskowitz A, Berg K, Grossestreuer A, Balaji L, Liu X, Cocchi M, et al.
Am J Respir Crit Care Med . 2023 Jun; 208(5):570-578. PMID: 37364280
Kidney injury is common and associated with worse outcomes in patients with septic shock. Mitochondrial resuscitation with thiamine (vitamin B1) may attenuate septic kidney injury. To assess whether thiamine supplementation...
3.
Cocchi M, Dargin J, Chase M, Patel P, Grossestreuer A, Balaji L, et al.
Shock . 2022 Jan; 57(4):508-517. PMID: 35066509
Introduction: Septic shock is often characterized by tachycardia and a hyperdynamic hemodynamic profile. Use of the beta antagonist esmolol has been proposed as a therapy to lower heart rate, thereby...
4.
Moskowitz A, Berg K, Cocchi M, Grossestreuer A, Issa M, Balaji L, et al.
Crit Care Explor . 2021 Nov; 3(10):e0557. PMID: 34729489
Design: Prospective, observational study. Setting: ICUs of a single tertiary care center. Patients: Patients hospitalized in the ICUs between August 2017 and November 2019. Interventions: A comprehensive trigger and response...
5.
Holmberg M, Andersen L, Moskowitz A, Berg K, Cocchi M, Chase M, et al.
Resuscitation . 2021 Feb; 162:388-395. PMID: 33577964
Introduction: Ubiquinol (reduced coenzyme Q10) is essential for adequate aerobic metabolism. The objective of this trial was to determine whether ubiquinol administration in patients resuscitated from cardiac arrest could increase...
6.
Grossestreuer A, Moskowitz A, Andersen L, Holmberg M, Konacki V, Berg K, et al.
Crit Care Explor . 2020 Nov; 2(12):e0270. PMID: 33251516
Design: Secondary analysis of the Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis randomized controlled trial (NCT03389555). Setting: Thirteen tertiary-care hospitals in the United States. Patients: Patients who were enrolled in...
7.
Moskowitz A, Andersen L, Rittenberger J, Swor R, Seethala R, Kurz M, et al.
J Am Heart Assoc . 2020 Aug; 9(17):e017171. PMID: 32851921
Background Neuromuscular blockade (NMB) agents are often administered to control shivering during targeted temperature management following cardiac arrest. In this study, we hypothesized that early, continuous NMB would result in...
8.
Moskowitz A, Huang D, Hou P, Gong J, Doshi P, Grossestreuer A, et al.
JAMA . 2020 Aug; 324(7):642-650. PMID: 32809003
Importance: The combination of ascorbic acid, corticosteroids, and thiamine has been identified as a potential therapy for septic shock. Objective: To determine whether the combination of ascorbic acid, corticosteroids, and...
9.
Mortensen S, Hurley M, Blewett L, Uber A, Yassa D, MacDonald M, et al.
Intern Emerg Med . 2020 Feb; 15(4):701-709. PMID: 32052366
This study aims to describe infectious complications in both out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA) patients with sustained return of spontaneous circulation (ROSC) and to compare differences...
10.
Moskowitz A, Berg K, Cocchi M, Chase M, Yang J, Sarge J, et al.
Resuscitation . 2019 Sep; 145:15-20. PMID: 31521775
Aim: Cardiac arrest in the intensive care unit (ICU-CA) is a common and highly morbid event. We investigated the preventability of ICU-CAs and identified targets for future intervention. Methods: This...